anayamalik, Author at European Medical Journal - Page 74 of 120

High Hepatitis C Cure Rate After Retreatment in People Who Inject Drugs

New data from the U.S.-based HERO Study shed light on an important question for hepatitis C virus (HCV) management: How effective is retreatment among people who inject drugs (PWID)?

Laser vs Diathermy: OA Treatment Outcomes Comparison Trial

In a randomized trial, researchers evaluated two physical therapy approaches—high-intensity laser therapy (HILT) and short-wave diathermy (SWD), each combined with exercise, for treating patients with Stage 2–3 knee osteoarthritis.

Cognitive-Behavioral Clues: Understanding of Body Dysmorphic Disorder

A new systematic review and meta-analysis sheds light on the evolving understanding of body dysmorphic disorder (BDD), presented in line with recent psychiatric research updates.

Phase II Trial Shows Clinical and Imaging Evidence of Brain Repair in MS: AAN 2025

At the American Academy of Neurology (AAN) Annual Meeting 2025, researchers presented new data from the long-term open-label extension of the Phase II VISIONARY-MS trial, reporting imaging and physiologic findings consistent with improved neuronal function and remyelination in patients with multiple sclerosis (MS).

Can Electronic Symptom Monitoring Transform Cancer Care?

Electronic patient-reported outcomes (ePROs) are increasingly seen as a promising tool to improve cancer care quality, especially for patients with metastatic disease.

Revolutionary 'Lab-in-Tube' Test Offers Rapid, Low-Cost TB Diagnosis

A fast, low-cost tuberculosis (TB) test that delivers results in under an hour from blood, saliva, or sputum samples could dramatically improve care in both well-equipped hospitals and resource-limited settings.

Reinforcing Benefits of Antimicrobial Stewardship Programs in Treating Pneumonia

A new systematic review and meta-analysis sheds light on the growing role of antimicrobial stewardship programs (ASPs) in improving clinical outcomes for hospitalized adults with community-acquired pneumonia (CAP), a condition that remains a leading cause of hospitalization and antibiotic use in the United States.

Steroid Dependency Persists in Late-Onset Rheumatoid Arthritis

In older adults with newly diagnosed late-onset rheumatoid arthritis (LORA), long-term glucocorticoid (GC) use remains persistent for a notable subset, according to a new analysis of national Medicare data spanning nearly a decade.

Exercise Before Bladder Cancer Surgery: Mixed Evidence on Prehabilitation

A new systematic review sheds light on how prehabilitation, interventions initiated before treatment, may influence long-term physical function and patient-reported outcomes in people affected by bladder cancer.

Telitacicept Phase III Trial Results for Generalized Myasthenia Gravis: AAN 2025

At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, new late-breaking data from a Phase III clinical trial highlighted the efficacy and safety of telitacicept in patients with generalized myasthenia gravis (gMG).